MC

483.1

-3.34%↓

SANES

10.324

-0.44%↓

SAF

316

+0.7%↑

BBVA

19.21

-1.23%↓

BNP

89.28

-0.46%↓

MC

483.1

-3.34%↓

SANES

10.324

-0.44%↓

SAF

316

+0.7%↑

BBVA

19.21

-1.23%↓

BNP

89.28

-0.46%↓

MC

483.1

-3.34%↓

SANES

10.324

-0.44%↓

SAF

316

+0.7%↑

BBVA

19.21

-1.23%↓

BNP

89.28

-0.46%↓

MC

483.1

-3.34%↓

SANES

10.324

-0.44%↓

SAF

316

+0.7%↑

BBVA

19.21

-1.23%↓

BNP

89.28

-0.46%↓

MC

483.1

-3.34%↓

SANES

10.324

-0.44%↓

SAF

316

+0.7%↑

BBVA

19.21

-1.23%↓

BNP

89.28

-0.46%↓

Search

Sartorius Stedim Biotech.

Closed

SectorFinance

168.1 -2.94

Overview

Share price change

24h

Current

Min

167.1

Max

173.2

Key metrics

By Trading Economics

Income

-17M

47M

Sales

67M

772M

P/E

Sector Avg

62.169

37.917

Dividend yield

0.41

Profit margin

6.125

Employees

9,753

EBITDA

-19M

199M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+40.96% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.41%

4.79%

Next Earnings

23 Apr 2026

Market Stats

By TradingEconomics

Market Cap

-1.8B

16B

Previous open

171.04

Previous close

168.1

Technical Score

By Trading Central

Confidence

Bullish Evidence

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

9 Apr 2026, 18:16 UTC

Major News Events

Bank of Mexico Cautious After Interest-Rate Cut, Minutes Show

9 Apr 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 Apr 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 Apr 2026, 23:14 UTC

Market Talk

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 Apr 2026, 23:14 UTC

Market Talk

Global Equities Roundup: Market Talk

9 Apr 2026, 23:07 UTC

Market Talk

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 Apr 2026, 22:54 UTC

Market Talk

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 Apr 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 Apr 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 Apr 2026, 20:57 UTC

Major News Events

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 Apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 Apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Apr 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 Apr 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 Apr 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 Apr 2026, 20:25 UTC

Acquisitions, Mergers, Takeovers

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 Apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 Apr 2026, 19:30 UTC

Major News Events

How Digital Currencies Have Helped Iran -- WSJ

9 Apr 2026, 19:25 UTC

Market Talk

Crude Futures End Volatile Session Higher -- Market Talk

9 Apr 2026, 19:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 Apr 2026, 19:16 UTC

Market Talk

Livestock Mixed After USDA Cuts Production Outlook -- Market Talk

9 Apr 2026, 18:55 UTC

Market Talk

Global Energy Roundup: Market Talk

9 Apr 2026, 18:55 UTC

Market Talk

U.S. Natural Gas Futures Fall On Weather, Storage Data -- Market Talk

9 Apr 2026, 18:50 UTC

Acquisitions, Mergers, Takeovers

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 Apr 2026, 18:44 UTC

Market Talk

Global Equities Roundup: Market Talk

9 Apr 2026, 18:44 UTC

Market Talk

Barrick's Former CEO Paid Severance Package of More Than $21 Million -- Market Talk

9 Apr 2026, 18:20 UTC

Market Talk
Major News Events

Oil Pulls Back As Israel to Negotiate With Lebanon -- Market Talk

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

40.96% upside

12 Months Forecast

Average 233 EUR  40.96%

High 262 EUR

Low 210 EUR

Based on 8 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

202.7 / 211.7Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat